30
Participants
Start Date
April 30, 2015
Primary Completion Date
July 31, 2021
Study Completion Date
December 31, 2022
Midodrine Hydrochloride
Midodrine hydrochloride is an approved medication used to treat low blood pressure. We are using a standard dose of 10 mg (tablet) only one time to determine if the vascular-constricting effects of this drug will help keep warm blood closer to the body's core and improve the ability to maintain Tcore in a cool environment (off-label use). A physician will administer the drug once before the cool thermal challenge in subjects with tetraplegia only (Visit 2).
Cool Temperature
Subjects will be exposed to a routinely encountered cool temperature (64° F) for up to to 2 hours depending on the vital signs (BP, HR, Tcore) and tolerance (comfort).
Center of Excellence for the Medical Consequences of SCI, James J Peters VAMC, The Bronx
The Craig H. Neilsen Foundation
OTHER
James J. Peters Veterans Affairs Medical Center
FED